• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AOMORI OLYMPUS CO., LTD. SINGLE USE 3-LUMEN NEEDLE KNIFE V

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AOMORI OLYMPUS CO., LTD. SINGLE USE 3-LUMEN NEEDLE KNIFE V Back to Search Results
Model Number KD-V451M
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Hemorrhage/Blood Loss/Bleeding (1888); Pancreatitis (4481); Unspecified Hepatic or Biliary Problem (4493)
Date of Event 07/18/2022
Type of Reportable Event Serious Injury
Event or Problem Description
Olympus reviewed the following literature titled, "clinical benefit of early precut sphincintroterotomy for difficult biliary cannulation during endoscopic retrograde cholangiopancreatography" objectives a precut procedure is sometimes required for difficult biliary cannulation during endoscopic retrograde cholangiopancreatography (ercp).However, it is unclear whether the biliary access rate has improved for early precut procedures compared to conventional techniques.This study aimed to identify the beneft of early precut sphincterotomy in cases showing difcult biliary access.Methods between april 2017 and august 2021, consecutive patients who underwent precutting for difcult biliary cannulation were retrospectively enrolled.The outcomes of early (=10 min from start of cannulation) and delayed (>10 min) precut groups were evaluated.All adverse events were defned according to cotton criteria.Results a total of 70 patients were enrolled in this study.The biliary cannulation rate for a frst ercp was signifcantly higher in the early compared to delayed precut group (95% vs.73.3%; p=0.015).A diference in overall cannulation rate between the two groups was not observed (97.5% vs.83.3%; p>0.05).Signifcantly higher rates of prophylactic pancreatic stents were described in the delayed compared to early precut group (36.7% vs.12.5%; p=0.009).Signifcant diferences in the frequency of pancreatitis, bleeding, penetration, and perforation were not noted between the two groups.Overall, the success rate was statistically signifcant between the experienced and less experienced endoscopists (87.2% vs.63.9%; p=0.017).Conclusions early precutting within 10 min from the start of cannulation in ercp is safe and efective in cases with a diffcult biliary cannulation, and can improve the biliary cannulation rate.Type of adverse events/number of patients (early precut) post-ercp pancreatitis - 3 patients bleeding - 2 patients retroperitoneal penetration - 1 patient (delayed precut) post-ercp pancreatitis - 3 patients bleeding - 2 patients retroperitoneal penetration - 1 patient this literature article requires 2 reports.The related patient identifiers are as follows: 1.(b)(6)/tjf-260v 2.(b)(6)/kd-v451m this medwatch report is for patient identifier (b)(6).There is no report of any olympus device malfunction in any procedure described in this study.
 
Additional Manufacturer Narrative
Since the literature described "needle cut 3 v" we selected "kd-v451m" which were shipped the most in the area and in the study period, were used.The suspect device has not been returned to olympus for evaluation.The investigation is in process.The literature article is attached for additional information.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
 
Event or Problem Description
This literature article requires 3 reports.The related patient identifiers are as follows: 1.(b)(6).2.(b)(6).3.(b)(6).
 
Additional Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse events cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.Olympus will continue to monitor field performance for this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SINGLE USE 3-LUMEN NEEDLE KNIFE V
Common Device Name
SINGLE USE 3-LUMEN NEEDLE KNIFE
Manufacturer (Section D)
AOMORI OLYMPUS CO., LTD.
2-248-1 okkonoki
kuroishi-shi, aomori 036-0 357
JA  036-0357
Manufacturer (Section G)
AOMORI OLYMPUS CO., LTD.
2-248-1 okkonoki
kuroishi-shi, aomori
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key16640695
Report Number9614641-2023-00447
Device Sequence Number5368035
Product Code KNS
UDI-Device Identifier04953170382710
UDI-Public04953170382710
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K955247
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Study,Literature,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 05/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberKD-V451M
Device Lot NumberUNKNOWN(LITERATURE)
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/27/2023
Supplement Date Received by Manufacturer04/24/2023
Initial Report FDA Received Date03/29/2023
Supplement Report FDA Received Date05/11/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
NON-OLYMPUS: CANNULA; NON-OLYMPUS: ERBE
Outcome Attributed to Adverse Event Other; Required Intervention;
Patient SexUnknown
-
-